Speaker Series – Cannabidiol: first-in-class antiseizure medicine for Dravet syndrome

We’re delighted to add a summary of a recent speaker event titled: Epidyolex (Cannabidiol): the first-in-class antiseizure medicine for seizures associated with Dravet syndrome.

The presentation was given by Laureate Professor Ingrid Scheffer, a paediatric neurologist and epileptologist at the University of Melbourne and Austin Health; and Professor Helen Cross, Head of the Developmental Neuroscience Programme at UCL-Great Ormond Street Institute of Child Health, UK.

Please login below to download this issue (PDF)

Subscribe